Insmed Inc. buy Royal Bank of Canada
Start price
11.06.25
/
50%
€86.50
Target price
11.06.26
€92.91
Performance (%)
-5.45%
Price
05.06.26
€89.19
This prediction will end soon
Summary
This prediction is currently active. With a performance of -5.45%, the BUY prediction for Insmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 11.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.439% | -2.439% |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Royal Bank of Canada from $99.00 to $106.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat